Loading...

Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor

Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oxf Med Case Reports
Main Authors: Gurbani, Saumya S, Weinberg, Brent D, Salgado, Eric, Voloschin, Alfredo, Velazquez Vega, Jose Enrique, Olson, Jeffrey J, Shu, Hui-Kuo G, Shim, Hyunsuk
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104214/
https://ncbi.nlm.nih.gov/pubmed/32257248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!